Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTOS-HA vs Lumify in Ocular Redness
NCT06803654Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- May 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine tartrate + sodium hyaluronate in ocular redness, sponsored by Bausch + Lomb. Started May 2025; status: completed.
02
Drugs
brimonidine tartrate + sodium hyaluronate
03
Conditions
ocular redness
Beyond the preview
Go deeper on NCT06803654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06803654.